Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Maione

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2011
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II studyC Gridelli, F Morgillo, A Favaretto, et al.
Critical Reviews in Oncology/Hematology|December 18, 2007
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel MeetingC Gridelli, P Maione, D Amoroso, et al.
British Journal of Cancer|November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 studyC Gridelli, C Gallo, M Di Maio, et al.
British Journal of Cancer|September 11, 2003
Supportive care in patients with advanced non-small-cell lung cancerM Di Maio, F Perrone, C Gallo, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2011
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II studyC Gridelli, F Morgillo, A Favaretto, et al.
Critical Reviews in Oncology/Hematology|December 18, 2007
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel MeetingC Gridelli, P Maione, D Amoroso, et al.
British Journal of Cancer|November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 studyC Gridelli, C Gallo, M Di Maio, et al.
British Journal of Cancer|September 11, 2003
Supportive care in patients with advanced non-small-cell lung cancerM Di Maio, F Perrone, C Gallo, et al.
Pageof 3